Review of Cipher Pharmaceuticals

AUG 16, 2018 - Dermatology pharmaceutical business with recent acquisition and growth in product pipeline, with some mixed results in the past. Coverage dropped until some visibility emerges.

Download Report

• Cipher Pharmaceuticals Inc. (CPH $17.60)
  • $17.60 P/E (TTM): 12.46X Cap: $447M
  • View CPH Profile
  • View Questions on CPH
  • View Reports on CPH
• Firan Technology Group Corporation (FTG $20.02)
  • $20.02 P/E (TTM): 41.07X Cap: $502M
  • View FTG Profile
  • View Questions on FTG
  • View Reports on FTG
• 5N Plus Inc. (VNP $33.05)
  • $33.05 P/E (TTM): 40.48X Cap: $2.94B
  • View VNP Profile
  • View Questions on VNP
• Hammond Power Solutions Inc. Class A Subordinate Voting Shares (HPS.A $289.30)
  • $289.30 P/E (TTM): 45.99X Cap: $3.44B
  • View HPS.A Profile
  • View Questions on HPS.A
• Kraken Robotics Inc. (PNG $7.65)
  • $7.65 Cap: $2.39B
  • View PNG Profile
  • View Questions on PNG
  • View Reports on PNG
• HIVE Digital Technologies Ltd. (HIVE $3.35)
  • $3.35 Cap: $817M
  • View HIVE Profile
  • View Questions on HIVE
• Zedcor Inc. (ZDC $6.20)
  • $6.20 P/E (TTM): 318.5X Cap: $693M
  • View ZDC Profile
  • View Questions on ZDC
• Char Technologies Ltd. (YES $0.30)
  • $0.30 Cap: $39M
  • View YES Profile
  • View Questions on YES
• Tantalus Systems Holding Inc. (GRID $6.45)
  • $6.45 Cap: $355M
  • View GRID Profile
  • View Questions on GRID
• Telesat Corporation Common and Variable Voting Shares (TSAT $66.66)
  • $66.66 Cap: $2.41B
  • View TSAT Profile
  • View Questions on TSAT
• Electrovaya Inc. (ELVA $12.59)
  • $12.59 P/E (TTM): 88.95X Cap: $604M
  • View ELVA Profile
  • View Questions on ELVA

Q: What are your thoughts on Char Technologies? Too early to invest? What other small caps would you invest in instead for a 5-year hold?

Upvote 13

Read Answer Asked by V on April 21, 2026

• Kelt Exploration Ltd. (KEL $10.06)
  • $10.06 P/E (TTM): 33.5X Cap: $2.01B
  • View KEL Profile
  • View Questions on KEL
• Thomson Reuters Corporation (TRI $131.91)
  • $131.91 P/E (TTM): 27.72X Cap: $57.81B
  • View TRI Profile
  • View Questions on TRI
• Cipher Pharmaceuticals Inc. (CPH $17.60)
  • $17.60 P/E (TTM): 12.46X Cap: $447M
  • View CPH Profile
  • View Questions on CPH
  • View Reports on CPH
• goeasy Ltd. (GSY $33.46)
  • $33.46 P/E (TTM): 2.44X Cap: $564M
  • View GSY Profile
  • View Questions on GSY
  • View Reports on GSY
• Capstone Copper Corp. (CS $11.33)
  • $11.33 P/E (TTM): 19.1X Cap: $8.64B
  • View CS Profile
  • View Questions on CS
• Tamarack Valley Energy Ltd. (TVE $12.69)
  • $12.69 Cap: $6.16B
  • View TVE Profile
  • View Questions on TVE
• Hammond Power Solutions Inc. Class A Subordinate Voting Shares (HPS.A $289.30)
  • $289.30 P/E (TTM): 45.99X Cap: $3.44B
  • View HPS.A Profile
  • View Questions on HPS.A
• Kraken Robotics Inc. (PNG $7.65)
  • $7.65 Cap: $2.39B
  • View PNG Profile
  • View Questions on PNG
  • View Reports on PNG
• Silvercorp Metals Inc. (SVM $16.34)
  • $16.34 Cap: $3.59B
  • View SVM Profile
  • View Questions on SVM
• Vitalhub Corp. (VHI $8.05)
  • $8.05 P/E (TTM): 81.0X Cap: $507M
  • View VHI Profile
  • View Questions on VHI
  • View Reports on VHI
• Tantalus Systems Holding Inc. (GRID $6.45)
  • $6.45 Cap: $355M
  • View GRID Profile
  • View Questions on GRID
• Propel Holdings Inc. (PRL $21.65)
  • $21.65 P/E (TTM): 10.73X Cap: $861M
  • View PRL Profile
  • View Questions on PRL
  • View Reports on PRL
• Telesat Corporation Common and Variable Voting Shares (TSAT $66.66)
  • $66.66 Cap: $2.41B
  • View TSAT Profile
  • View Questions on TSAT

Q: Would you consider all positions in your growth portfolio still buyable today? Are there any that would make you pause if you were buying now?

Upvote 13

Read Answer Asked by Sylvia on March 18, 2026

• Cipher Pharmaceuticals Inc. (CPH $17.60)
  • $17.60 P/E (TTM): 12.46X Cap: $447M
  • View CPH Profile
  • View Questions on CPH
  • View Reports on CPH

Q: Clearly the Street was very impressed with CPH's Q4 and YE earnings that were released on Friday (up 17% despite another tough day in the markets). As always, I would appreciate your view.

Upvote 4

Read Answer Asked by karl on March 16, 2026